S
Suguru Yonezawa
Researcher at Kagoshima University
Publications - 195
Citations - 10432
Suguru Yonezawa is an academic researcher from Kagoshima University. The author has contributed to research in topics: Mucin & MUC1. The author has an hindex of 52, co-authored 195 publications receiving 9888 citations. Previous affiliations of Suguru Yonezawa include Otsuka Pharmaceutical & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms
Ralph H. Hruban,Kyoichi Takaori,David S. Klimstra,N. Volkan Adsay,Jorge Albores-Saavedra,Andrew V. Biankin,Sandra A. Biankin,Carolyn C. Compton,Noriyoshi Fukushima,Toru Furukawa,Michael Goggins,Yo Kato,Günter Klöppel,Daniel S. Longnecker,Jutta Lüttges,Anirban Maitra,G. Johan A. Offerhaus,Michio Shimizu,Suguru Yonezawa +18 more
TL;DR: The purpose of this meeting was to define an international acceptable set of diagnostic criteria for PanINs and IPMNs and to address a number of ambiguities that exist in the previously reported classification systems for these neoplasms.
Journal ArticleDOI
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.
Toru Furukawa,Günter Klöppel,N. Volkan Adsay,Jorge Albores-Saavedra,Noriyoshi Fukushima,Akira Horii,Ralph H. Hruban,Yo Kato,David S. Klimstra,Daniel S. Longnecker,Jutta Lüttges,G. Johan A. Offerhaus,Michio Shimizu,Makoto Sunamura,Arief A. Suriawinata,Kyoichi Takaori,Suguru Yonezawa +16 more
TL;DR: A consensus nomenclature and criteria for classifying variants as distinctive IPMN subtypes including gastric type, intestinal type, pancreatobiliary type, and oncocytic type are defined and can be used for further analyses of the clinicopathological significance of the variations of IPMN.
Journal Article
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study (vol 447, pg 794, 2005)
Toru Furukawa,Guenter Kloeppel,Adsay,Jorge Albores-Saavedra,Noriyoshi Fukushima,Akira Horii,Ralph H. Hruban,Yo Kato,David S. Klimstra,Daniel S. Longnecker,Jutta Luettges,G. Johan A. Offerhaus,Michio Shimizu,Makoto Sunamura,Arief A. Suriawinata,Kyoichi Takaori,Suguru Yonezawa +16 more
TL;DR: A consensus classification of intraductal papillary-mucinous neoplasms (IPMNs) was established at a meeting of international experts on pancreatic precursor lesions held in 2003.
Journal ArticleDOI
Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas
Toru Furukawa,Takashi Hatori,Izumi Fujita,Masakazu Yamamoto,Makio Kobayashi,Nobuyuki Ohike,Toshio Morohoshi,Shinichi Egawa,Michiaki Unno,Sonshin Takao,Masahiko Osako,Suguru Yonezawa,Mari Mino-Kenudson,Gregory Y. Lauwers,Hiroshi Yamaguchi,Shinichi Ban,Michio Shimizu +16 more
TL;DR: Investigation of four morphological types of intraductal papillary mucinous neoplasms of the pancreas found that the morphological type of IPMN appears to be an independent predictor of patient prognosis.
Journal ArticleDOI
Midkine, A Retinoic Acid-Inducible Growth/Differentiation Factor: Immunochemical Evidence for the Function and Distribution
TL;DR: Results suggest that MK is an endogenous neurite outgrowth factor involved in the development of the central nervous system and found to inhibit growth of Wilms' tumor cells, which secreted MK into culture medium.